Balchem Corporation will present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025.
Quiver AI Summary
Balchem Corporation, a manufacturer of specialty ingredients for health and nutrition, has announced its participation in Baird’s 55th Annual Global Industrial Conference on November 12, 2025. The presentation will be made by key executives including Chairman and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director of Investor Relations Allison Baurichter. Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries through its three main business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, which cater to food and beverage, animal health, and healthcare markets, among others.
Potential Positives
- Balchem Corporation will present at a significant industry event, Baird’s 55th Annual Global Industrial Conference, showcasing its leadership and commitment to engaging with investors and industry stakeholders.
- The presentation will be led by key executives, including the Chairman and CEO, indicating a strong message about the company's strategic direction and potential for growth.
- Balchem’s diverse business segments, including Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, highlight its broad market reach and ability to cater to various industries, which can attract investor interest.
- The focus on developing specialty ingredients that enhance health and well-being positions Balchem favorably within the growing health and nutrition markets, aligning with current consumer trends.
Potential Negatives
- None
FAQ
What is the date of Balchem Corporation's presentation at the Baird Global Industrial Conference?
Balchem Corporation will present at the Baird's 55th Annual Global Industrial Conference on November 12, 2025.
Who will represent Balchem Corporation at the conference?
Ted Harris, Martin Bengtsson, and Allison Baurichter will represent Balchem Corporation at the conference.
What are the main business segments of Balchem Corporation?
Balchem Corporation reports three main segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
What types of products does Balchem Corporation offer?
Balchem manufactures specialty ingredients for health and nutrition, including customized food systems and chelated minerals.
How can I contact Balchem Corporation for more information?
You can contact Jacqueline Yarmolowicz at Balchem Corporation by phone at 845-326-5600.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$BCPC Hedge Fund Activity
We have seen 206 institutional investors add shares of $BCPC stock to their portfolio, and 162 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- APG ASSET MANAGEMENT N.V. removed 917,284 shares (-79.4%) from their portfolio in Q2 2025, for an estimated $146,031,612
- ASSENAGON ASSET MANAGEMENT S.A. added 191,621 shares (+221.3%) to their portfolio in Q3 2025, for an estimated $28,754,647
- CONESTOGA CAPITAL ADVISORS, LLC added 125,411 shares (+10.9%) to their portfolio in Q3 2025, for an estimated $18,819,174
- BLACKROCK, INC. removed 112,431 shares (-2.2%) from their portfolio in Q2 2025, for an estimated $17,899,015
- WASATCH ADVISORS LP removed 108,916 shares (-10.2%) from their portfolio in Q2 2025, for an estimated $17,339,427
- TRIBUTARY CAPITAL MANAGEMENT, LLC added 108,740 shares (+86.9%) to their portfolio in Q3 2025, for an estimated $16,317,524
- PITCAIRN CO added 102,013 shares (+3083.8%) to their portfolio in Q2 2025, for an estimated $16,240,469
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BCPC Analyst Ratings
Wall Street analysts have issued reports on $BCPC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 10/22/2025
To track analyst ratings and price targets for $BCPC, check out Quiver Quantitative's $BCPC forecast page.
Full Release
MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird’s 55 th Annual Global Industrial Conference on November 12, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations, will present at the conference.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
| Contact: | Jacqueline Yarmolowicz |
| Balchem Corporation (Telephone: 845-326-5600) |
